Eric Lattmann

Title: Innovations of Eric Lattmann

Introduction

Eric Lattmann is a notable inventor based in Birmingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiproliferative agents. With a total of three patents to his name, Lattmann's work focuses on innovative compounds that have the potential to impact cancer treatment and other medical applications.

Latest Patents

Lattmann's latest patents include inventions related to certain dioxodihydropyridine derivatives and their precursors. These compounds are designed for use as anti-proliferative agents, specifically targeting tumor growth and serving as anti-cancer agents. Additionally, they have applications as antibiotics and antiviral agents, showcasing the versatility and importance of his research.

Career Highlights

Throughout his career, Eric Lattmann has worked with Epx Research Limited, where he has contributed to various projects aimed at advancing pharmaceutical science. His expertise in the field has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Lattmann has collaborated with professionals such as Washington Odur Ayuko and Michael John Tisdale, further enhancing the impact of his work through teamwork and shared expertise.

Conclusion

Eric Lattmann's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work in developing antiproliferative agents is a testament to his dedication to improving health outcomes.